Preview

Current Pediatrics

Advanced search

Ichthyosis Follicularis, Atrichia, and Photophobia (IFAP) Syndrome, Type 2: Clinical Case

https://doi.org/10.15690/vsp.v23i3.2759

Abstract

Background. Ichthyosis follicularis with atrichia and photophobia (IFAP syndrome), type 2 is a rare hereditary disease from the group of syndromic forms of ichthyosis. It is clinically characterized by triad of non-inflammatory follicular ichthyosis, total or subtotal alopecia at birth or shortly after, and photophobia of different severity. There is no etiotropic therapy for IFAP syndrome, while symptomatic treatment (emollients, keratolytics, retinoids) is aimed on stabilizing the patient’s condition and maintaining the optimal quality of life. About 60 cases of IFAP syndrome have been described worldwide by 2023, and none in Russia.

Clinical case description. The girl, 2 years 3 months old, had signs of xeroderma, follicular hyperkeratosis, photophobia with lacrimation, and alopecia. The diagnosis of “ichthyosis follicularis with atrichia and photophobia (IFAP syndrome), type 2, autosomal dominant” was established according to anamnesis, clinical signs, and results of whole-exome sequencing, followed by validation of the identified nucleotide variant chr17:17720597G>A, p.1669C>T (p.Arg557Cys NM_001005291.2) in exon 9 of the SREBF1 gene via direct automatic sequencing in the patient and both parents (not revealed in her parents).

Conclusion. Molecular genetic testing is crucial to establish IFAP syndrome as clinical signs of the disease are similar to other dermatoses. However, physicians need to have clinical suspicion when identifying cases of follicular ichthyosis in combination with alopecia and photophobia at or shortly after birth to timely diagnose IFAP syndrome and thus prevent any treatment delays.

About the Authors

Eduard T. Ambarchyan
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation

Moscow


Disclosure of interest:

receiving research grants from pharmaceutical companies Eli Lilly, Novartis, AbbVie, Pfizer, Amryt Pharma plc, scientific consultant of Johnson & Johnson



Anastasiya D. Kuzminova
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation

Moscow


Disclosure of interest:

The other contributors confirmed the absence of a reportable conflict of interests



Totuy K. Eldarova
Pirogov Russian National Research Medical University
Russian Federation

Moscow


Disclosure of interest:

The other contributors confirmed the absence of a reportable conflict of interests



Vladislav V. Ivanchikov
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation

Moscow


Disclosure of interest:

The other contributors confirmed the absence of a reportable conflict of interests



Nataliya V. Zhurkova
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation

Moscow


Disclosure of interest:

lecturing for pharmaceutical companies Takeda, Sanofi Aventis Group, AstraZeneca, Chiesi pharmaceuticals, Nutricia



Nato D. Vashakmadze
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery; Pirogov Russian National Research Medical University
Russian Federation

Moscow


Disclosure of interest:

lecturing for pharmaceutical companies Takeda, Sanofi Aventis Group, Biomarin, Nanolek, Chiesi pharmaceuticals, Nutricia, AstraZeneca



References

1. Saat H, Sahin I, Duzkale N, et al. Genetic etiology of ichthyosis in Turkish patients: Next-generation sequencing identified seven novel mutations. Medeni Med J. 2022;37(2):126–130. https://doi.org/10.4274/mmj.galenos.2022.39924

2. Ikhtioz u detei: clinical guidelines. Union of Pediatricians of Russia; 2016. p. 6. (In Russ).

3. Oji V, Tadini G, Akiyama M, et al. Revised nomenclature and classification of inherited ichthyoses: Results of the first Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol. 2010;63(4):607–641. https://doi.org/10.1016/j.jaad.2009.11.020

4. Mazereeuw-Hautier J, Vahlquist A, Traupe H, et al. Management of Congenital ichthyoses: European guidelines of care, part one. Br J Dermatol. 2018;180(2):272–281. https://doi.org/10.1111/bjd.17203

5. McLeod JM. Three cases of ‘ichthyosis follicularis’ associated with baldness. Br J Dermatol. 1909;21:165–189.

6. Wang H, Humbatova A, Liu Y, et al. Mutations in SREBF1, Encoding Sterol Regulatory Element Binding Transcription Factor 1, Cause Autosomal-Dominant IFAP Syndrome. Am J Hum Genet. 2020;107(1):34–45. https://doi.org/10.1016/j.ajhg.2020.05.006

7. Morice-Picard F, Michaud V, Lasseaux E, et al. Hereditary Mucoepithelial Dysplasia Results from Heterozygous Variants at p.Arg557 Mutational Hotspot in SREBF1, Encoding a Transcription Factor Involved in Cholesterol Homeostasis. J Invest Dermatol. 2020;140(6):1289–1292.e2. https://doi.org/10.1016/j.jid.2019.10.014

8. Chacon-Camacho OF, Arce-Gonzalez R, Ordaz-Robles T, et al. Exome sequencing identifies a SREBF1 recurrent ARG557CYS mutation as the cause of hereditary mucoepithelial dysplasia in a family with high clinical variability. Am J Med Genet A. 2020;182(11):2773–2777. https://doi.org/10.1002/ajmg.a.61849

9. Migliavacca MP, Fock RA, Almeida N, et al. A Brazilian case of IFAP syndrome with severe congenital ichthyosis and limb malformations caused by a rare variant in MBTPS2. Rev Paul Pediatr. 2023;41:e2022057. https://doi.org/10.1590/1984-0462/2023/41/2022057

10. Okutman O, Muller J, Baert Y, et al. Exome sequencing reveals a nonsense mutation in TEX15 causing spermatogenic failure in a Turkish family. Hum Mol Genet. 2015;24(19):5581–5588. https://doi.org/10.1093/hmg/ddv290

11. Mao L, Wang Y, An L, et al. Molecular Mechanisms and Clinical Phenotypes of GJB2 Missense Variants. Biology (Basel). 2023;12(4):505. https://doi.org/10.3390/biology12040505

12. Irurzun I, Natale MI, Agostinelli ML, et. al. Ichthyosis follicularis, atrichia and photophobia (IFAP) and hereditary mucoepithelial dysplasia: Two syndromes that share a common clinical spectrum. Pediatr Dermatol. 2021;38(3):568–574. https://doi.org/10.1111/pde.14560

13. Nagakeerthana S, Rangaraj M, Karthikeyan K. Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome. Int J Trichology. 2017;9(2):67–69. https://doi.org/10.4103/ijt.ijt_69_16

14. Mégarbané H, Mégarbané A. Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome. Orphanet J Rare Dis. 2011;6:29. https://doi.org/10.1186/1750-1172-6-29

15. Traboulsi E, Waked N, Mégarbané H, Mégarbané A. Ocular findings in ichthyosis follicularis-alopecia-photophobia (IFAP) syndrome. Ophthalmic Genet. 2004;25(2):153–156. https://doi.org/10.1080/13816810490514405

16. Höpker LM, Ribeiro CG, Oliveira LM, Moreira AT. Ichthyosis follicularis, alopecia and photophobia syndrome (IFAP): report of the first case with ocular and cutaneous manifestations in Brazil with a favorable response to treatment. Arq Bras Oftalmol. 2011;74(1):55–57. https://doi.org/10.1590/s0004-27492011000100013

17. Cursiefen C, Schlötzer-Schrehardt U, Holbach LM, et al. Ocular findings in ichthyosis follicularis, atrichia, and photophobia syndrome. Arch Ophthalmol. 1999;117(5):681–684. https://doi.org/10.1001/archopht.117.5.681

18. Basilious A, Fung SSM, Ali A. Limbal Stem Cell Dysfunction in Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome. Cornea. 2020;39(10):1321–1324. https://doi.org/10.1097/ICO.0000000000002393

19. Cammarata-Scalisi F, Willoughby CE, Cárdenas Tadich A, et al. Clinical, etiopathogenic, and therapeutic aspects of KID syndrome. Dermatol Ther. 2020;33(4):e13507. https://doi.org/10.1111/dth.13507

20. Rajesh S, Loganathan E, Shanmukhappa AG. Ichthyosis Follicularis with Alopecia and Photophobia Syndrome with Coexisting Palmoplantar Keratoderma Treated with Acitretin. Int J Trichology. 2022;14(6):213–215. https://doi.org/10.4103/ijt.ijt_9_22


Review

For citations:


Ambarchyan E.T., Kuzminova A.D., Eldarova T.K., Ivanchikov V.V., Zhurkova N.V., Vashakmadze N.D. Ichthyosis Follicularis, Atrichia, and Photophobia (IFAP) Syndrome, Type 2: Clinical Case. Current Pediatrics. 2024;23(3):181-187. (In Russ.) https://doi.org/10.15690/vsp.v23i3.2759

Views: 413


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)